1. P168 Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis (IPF): one-year data from post-marketing surveillance in the united states. (15th November 2016) Authors: Maher, T; Noth, I; Allinger, A; Kaul, M; Conoscenti, CS; Oelberg, D Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P272 Epidemiology of idiopathic pulmonary fibrosis in the uk: findings from the british lung foundation's 'respiratory health of the nation' project. (15th November 2016) Authors: Snell, N; Strachan, D; Hubbard, R; Gibson, J; Maher, T; Jarrold, I Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S17 The burden of idiopathic pulmonary fibrosis in the united kingdom: a retrospective, matched cohort study. (15th November 2016) Authors: Storm, M; Tran, I; Strongman, H; Fredriksson, J; Maher, T Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P141 Differential expression of conventional and inhibitory VEGFA isoforms in normal and fibrotic fibroblasts–a potential role in IPF pathogenesis?. (14th November 2013) Authors: Barratt, SL; Blythe, T; Jarrett, C; Ourradi, K; Maher, T; Welsh, GI; Bates, DO; Millar, AB Journal: Thorax Issue: Volume 68(2013)Supplement 3 Page Start: A139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. S76 Pleuro-parenchymal fibroelastosis: traction bronchiectasis and extent of platythorax on computed tomography are determinants of disease progression and mortality. (December 2018) Authors: Chua, F; George, P; Devaraj, A; Armstrong-James, D; Renzoni, E; Wells, AU; Pulzato, I; Molyneaux, P; Maher, T; Kokosi, M; Kouranos, V; Margaritopoulos, G; Desai, S Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. S144 Mixed ventilatory defects in pulmonary sarcoidosis: prevalence and clinical features. (December 2018) Authors: Kouranos, V; Ward, S; Kokosi, M; Castillo, D; Chua, F; Judge, E; Thomas, S; Van Tonder, FV; Devaraj, A; Nicholson, A; Maher, T; Renzoni, E; Wells, AU Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P9 Nintedanib for the treatment of Idiopathic Pulmonary Fibrosis – initial clinical experience in a UK cohort. (12th November 2015) Authors: Fletcher, SV; Jones, MG; Renzoni, E; Parfrey, H; Hoyles, R; Spinks, K; Kokosi, M; Kwok, A; Warburton, C; Titmuss, V; Maher, T; Chua, F; Wells, A; Richeldi, L; Spencer, LG Journal: Thorax Issue: Volume 70(2015)Supplement 3 Page Start: A78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. S68 Bioavailability of VEGF in Idiopathic Pulmonary Fibrosis. (19th November 2012) Authors: Barratt, SL; Jarrett, C; Blythe, T; Welsh, GI; Maher, T; Bates, DO; Millar, AB Journal: Thorax Issue: Volume 67(2012)Supplement 2 Page Start: A34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. S2 Nocturnal hypoxaemia rather than obstructive sleep apnoea is associated with progressive deterioration in quality of life in patients with fibrotic interstitial lung disease. (11th November 2022) Authors: Myall, KJ; West, AG; Martinovic, JL; Lam, JL; Roque, D; Domi, V; Wu, Z; Jackson, DJ; Maher, T; Molyneaux, PL; Suh, ES; Kent, BD Journal: Thorax Issue: Volume 77(2022)Supplement 1 Page Start: A5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. S107 Disease progression modelling in idiopathic pulmonary fibrosis: a prediction of time to disease progression and life expectancy with pirfenidone. (12th November 2015) Authors: Fisher, M; Maher, T; Hill, C; Marshall, J Journal: Thorax Issue: Volume 70(2015)Supplement 3 Page Start: A61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗